Michael Farah

Michael Farah has been involved in principal investing and investment banking since 2001. Prior to Linden, he was a Vice President at Metalmark Capital where he focused on healthcare investing. Mr. Farah began his career at UBS Investment Bank where he focused on M&A advisory and capital raising transactions for the healthcare sector and also spent three years with Summit Partners as a private equity associate.

Mr. Farah holds a Bachelor of Arts in Finance, with honors, from Carnegie Mellon University and an MBA from Harvard Business School.

Company Blog

November 29, 2018
Industry Poll: How Can Your GMP Auditing Program Be Most…
Expert insight into how you can take steps to best improve your GMP auditing… Read More
November 15, 2018
The Important Role of Advanced Therapy Medicinal Products
Today on the blog, a personal perspective from a colleague on the impact and… Read More
October 16, 2018
Outdated Facilities – Bring Back the ‘c’ in cGMP
Bringing the ‘c’ in the cGMP status back into your facility, processes, or procedures… Read More
More Articles

UPCOMING Events

January 28, 2019
DIA Pharmacovigilance and Risk Management Strategies Conference
Join us at DIA’s Pharmacovigilance and Risk Management Strategies Conference for context, background,... Read More
February 18, 2019
SCOPE – Summit for Clinical Ops Executives
SCOPE Summit 2019 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-de... Read More
March 18, 2019
DIA Medical Affairs and Scientific Communications
DIA’s Medical Affairs and Scientific Communications Forum is designed for medical affairs professionals, b... Read More
All Events
Contact Us